USPTO serial 90820177
KAWIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 26, 2022
- Examiner
- ELTON, DAVID JONATHAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with KAWIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Beijing Kawin Technology Share-Holding Co., Ltd.
Yizhuang Beijing, CN
Other trademarks owned by Beijing Kawin Technology Share-Holding Co., Ltd.
Beijing Kawin Technology Share-Holding Co., Ltd.
Yizhuang Beijing, CN
Other trademarks owned by Beijing Kawin Technology Share-Holding Co., Ltd.
Beijing Kawin Technology Share-Holding Co., Ltd.
Yizhuang Beijing, CN
Other trademarks owned by Beijing Kawin Technology Share-Holding Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy H. Hiebert
TIMOTHY H. HIEBERT WOMBLE BOND DICKINSON (US) LLP470 ATLANTIC AVE.BOSTON, MA 02210-2228UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceuticals, namely, anti-infectives; Vaccines; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Chemical preparations for sanitary purposes; Pharmaceutical preparations for the prevention and treatment of cancer and tumors; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations, namely, anticoagulants; Reagent paper for medical purposes; Diagnostic preparations for medical purposes; Medical diagnostic reagent | ACTIVE | — |
| 042 | Pharmaceutical research services; Technological consulting services in the field of technology development, namely, in the field of developing biotechnology processes and procedures; Pharmaceutical drug development services; Drug research services; Development of pharmaceutical preparations and medicines; Chemical research; Conducting early evaluations in the field of new pharmaceuticals; Biological research and analysis; Biological research; Research and development services in the field of antibodies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Beijing Kawin Technology Share-Holding Co., Ltd.
- Other trademarks owned by Beijing Kawin Technology Share-Holding Co., Ltd.
- Other trademarks owned by Beijing Kawin Technology Share-Holding Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named KAWIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 26, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 26, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 10, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 10, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 20, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 4, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 13, 2021 | NWAP | NEW APPLICATION ENTERED | — |